Arndt, Susan
Wesarg, Thomas
Aschendorff, Antje
Speck, Iva
Hocke, Thomas
Jakob, Till Fabian
Rauch, Ann-Kathrin
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Accepted: 14 May 2023
First Online: 9 October 2023
Declarations
:
: S. Arndt states the following: Advanced Bionics: travel reimbursement, financial support for research; Cochlear: financial support for research, travel reimbursement; MED-EL: financial support for research, travel reimbursement; Oticon Medical: travel reimbursement, financial support for research. T. Wesarg states the following: Advanced Bionics: financial support for research, travel reimbursement; Cochlear: financial support for research, travel reimbursement; MED-EL: financial support for research, travel reimbursement. A. Aschendorff states the following: Advanced Bionics: financial support for research, medical advisory board, travel reimbursement; Cochlear: financial support for research, travel reimbursement; MED-EL: financial support for research, travel reimbursement; Oticon Medical: financial support for research, travel reimbursement. I. Speck states the following; Cochlear: travel reimbursement. T. Hocke is an employee of Cochlear Germany. T. F. Jakob, A.-K. Rauch declare that they have no competing interests.
: The present study was conducted with the approval of the Ethics Committee of the University of Freiburg (No. 21/1142) in accordance with national law and in accordance with the Declaration of Helsinki of 2013 (in the current, revised version; DRKS 00024640).
: The supplement containing this article is not sponsored by industry.